Dosing Recommendation for Cefoperazone-Sulbactam in Pediatric Uncomplicated UTI
For a 17 kg girl with uncomplicated UTI, administer cefoperazone-sulbactam 20 mg/kg every 6 hours (340 mg per dose, 1,360 mg total daily dose) as a 0.5-hour infusion for 5-7 days.
Rationale and Evidence Analysis
Primary Dosing Guidance
The most recent and relevant evidence comes from a 2025 population pharmacokinetic study 1 that specifically analyzed optimal dosing regimens for cefoperazone-sulbactam in pediatric patients. This study demonstrated that 20 mg/kg administered 4 times daily as a 0.5-hour infusion (using a 1:1 cefoperazone:sulbactam ratio) achieves the bactericidal target of 70% free time above MIC (70% fT>MIC) for community-acquired pathogens.
For this 17 kg patient:
- Single dose: 340 mg (20 mg/kg × 17 kg)
- Total daily dose: 1,360 mg (340 mg × 4 doses)
- Dosing interval: Every 6 hours
- Infusion time: 30 minutes
Supporting Historical Data
Multiple Japanese pediatric studies from 1984 2, 3, 4, 5 consistently used dosing ranges of 30-67 mg/kg/day divided into 3-4 doses for various pediatric infections including UTIs, with excellent efficacy rates (72-100%). These studies specifically documented successful treatment of urinary tract infections at approximately 20 mg/kg/day 2.
Duration of Therapy
For uncomplicated UTI in children, 5-7 days of treatment is appropriate based on general pediatric UTI guidelines 6. The WHO Pocket Book recommends 5 days for uncomplicated UTI with co-trimoxazole as a reference point 6.
Pharmacokinetic Considerations
The 2025 PK/PD study 1 established that:
- Age was not a statistically significant covariate in the pharmacokinetics of either cefoperazone or sulbactam
- Weight-based dosing is appropriate across the pediatric age range (0.83-14.6 years)
- The PK/PD breakpoint for 20 mg/kg four times daily covers MIC₉₀ values of common community-acquired pathogens (Streptococcus pneumoniae and Haemophilus influenzae at 0.125 μg/mL)
For uncomplicated UTI caused by typical uropathogens (E. coli, Proteus, Klebsiella), the standard dosing regimen provides adequate urinary concentrations, as demonstrated by urinary recovery rates of 57.8-100% for sulbactam and 18.3-27.7% for cefoperazone 5.
Important Caveats
When to Consider Higher Dosing
The 2025 study 1 notes that for nosocomial pathogens or complicated infections, a higher dose of 60 mg/kg four times daily as a 4-hour infusion (using a 2:1 ratio) may be necessary. However, this is not indicated for uncomplicated UTI in an otherwise healthy child.
Monitoring Parameters
- Clinical symptom resolution (typically within 48-72 hours)
- Urine culture if obtained pre-treatment
- Adverse effects: diarrhea (most common), transient GPT/GOT elevation, eosinophilia 3, 4
Contraindications and Precautions
- Ensure adequate renal function (though renal insufficiency does not significantly alter cefoperazone disposition)
- Avoid if history of severe β-lactam allergy
- The drug label 7 notes physical incompatibilities with multiple drugs; do not co-infuse in the same IV line
Alternative Considerations
If cefoperazone-sulbactam is unavailable or contraindicated, standard first-line agents for pediatric uncomplicated UTI include:
- Ceftriaxone: 50-75 mg/kg/day (850-1,275 mg/day for 17 kg child) 8, 9
- Cefotaxime: 150 mg/kg every 8 hours 8
- Oral options (if able to tolerate): nitrofurantoin 5-7 mg/kg/day divided 10, 9
The recommended regimen of 20 mg/kg every 6 hours provides optimal coverage for uncomplicated UTI while minimizing unnecessary broad-spectrum exposure and adverse effects.